A novel PAI-1 inhibitor prevents ageing-related muscle fiber atrophy
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 534, 849-856
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (JSPS) Kakenhi (18H02920)
- Japan Society for the Promotion of Science (JSPS) Kakenhi (18K09096)
This publication has 28 references indexed in Scilit:
- Sarcopenia: Aging-Related Loss of Muscle Mass and FunctionPhysiological Reviews, 2019
- Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseasesAgeing Research Reviews, 2018
- PAI-1–regulated extracellular proteolysis governs senescence and survival in Klotho miceProceedings of the National Academy of Sciences, 2014
- Three Decades of Research on Plasminogen Activator Inhibitor-1: A Multifaceted SerpinSeminars in Thrombosis and Hemostasis, 2013
- Increased plasminogen activator inhibitor type-1 (PAI-1) in the heart as a function of ageLife Sciences, 2006
- Aging Accelerates Endotoxin-Induced ThrombosisThe American Journal of Pathology, 2002
- Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivoBlood, 2002
- Plasmin and Matrix Metalloproteinases in Vascular RemodelingThrombosis and Haemostasis, 2001
- The plasminogen activator system: biology and regulationCellular and Molecular Life Sciences, 1999
- What is the cause of the ageing atrophy?Journal of the Neurological Sciences, 1988